![Xia Milly Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Xia Milly Chen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 17 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Xia Milly Chen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NOKIA OYJ | Telecommunications Equipment | Director/Board Member | |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TYME TECHNOLOGIES, INC. | Pharmaceuticals: Major | President | |
Brown University | College/University | Undergraduate Degree | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
Goldman Sachs & Co. LLC
![]() Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
University of Oxford | College/University | Graduate Degree Undergraduate Degree | |
The University of Manchester | College/University | Undergraduate Degree Doctorate Degree | |
Oxford Brookes University | College/University | Graduate Degree | |
Barclays Capital, Inc.
![]() Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Corporate Officer/Principal | |
Galapagos Biotech Ltd.
![]() Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
McGill University | College/University | Undergraduate Degree | |
The University of Southampton | College/University | Doctorate Degree | |
Waseda University | College/University | Graduate Degree | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Public Communications Contact | |
Nanjing University | College/University | Undergraduate Degree | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
SBVA
![]() SBVA Investment ManagersFinance SBVA (SBVA) is a private equity/venture capital subsidiary of SoftBank Korea Co., Ltd founded in 2000. The firm is headquartered in Seoul, South Korea. | Investment Managers | Private Equity Investor | |
Organon Biosciences, Inc. | Chief Tech/Sci/R&D Officer | ||
McCown De Leeuw & Co.
![]() McCown De Leeuw & Co. Investment ManagersFinance McCown De Leeuw & Co. is an American company that has been designing professional websites for clients in various industries since 1995. The private company's web design services aim to help clients build their brand and effectively communicate their message. | Investment Managers | Corporate Officer/Principal | |
ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Novo Principal Investments
![]() Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor | |
Moelis & Co. (UK) LLP
![]() Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Investment Banks/Brokers | Corporate Officer/Principal | |
Shanghai Yunfeng Investment Management Co. Ltd.
![]() Shanghai Yunfeng Investment Management Co. Ltd. Investment ManagersFinance Shanghai Yunfeng Investment Management Co. Ltd (Yunfeng Capital) is a private equity firm founded in 2010 by Feng Yu and Yun Ma. The firm is headquartered in Shanghai, China. | Investment Managers | Private Equity Investor | |
Science Exchange, Inc.
![]() Science Exchange, Inc. Internet Software/ServicesTechnology Services Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA. | Internet Software/Services | Director/Board Member | |
UROGEN PHARMA LTD. | Biotechnology | Investor Relations Contact | |
Harvard Business School | College/University | Masters Business Admin | |
Saïd Business School | College/University | Human Resources Officer | |
Transcelerate Biopharma, Inc.
![]() Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member | |
Integrated Clinical Oncology Network Pty Ltd.
![]() Integrated Clinical Oncology Network Pty Ltd. Hospital/Nursing ManagementHealth Services Integrated Clinical Oncology Network Pty Ltd. engages in the provision of cancer and hematological care services. It offers chemotherapy compunding, pharmacy management, remote radiation therapy planning, and medical physics services. The firm also offers patients the option of emerging treatment through clinical trials. The company was founded by Stuart Giles in 2012 and is headquartered in South Brisbane, Australia. | Hospital/Nursing Management | Director/Board Member | |
Pear Therapeutics (US), Inc.
![]() Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Packaged Software | Investor Relations Contact | |
Tempus Labs, Inc.
![]() Tempus Labs, Inc. Packaged SoftwareTechnology Services Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL. | Packaged Software | Director/Board Member | |
Mission Bio, Inc.
![]() Mission Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Aetion, Inc.
![]() Aetion, Inc. Packaged SoftwareTechnology Services Aetion, Inc. provides data analytics software solutions. The firm?s Aetion Evidence Platform enables life sciences customers to transform disparate data sets into evidence needed to make critical business decisions; and helps payers determine effective treatments for specific patient populations and measure impact in outcomes and utilization. The company was founded by Jeremy A. Rassen, Sebastian Schneeweiss and Allon Rauer in 2013 and is headquartered in New York, NY. | Packaged Software | Director of Finance/CFO | |
Exscientia AI Ltd.
![]() Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Generic | Chairman Director/Board Member Director of Finance/CFO Investor Relations Contact Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Public Communications Contact Human Resources Officer | |
Novo Holdings A/S (Investment Company)
![]() Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director/Board Member | |
Ohana Biosciences, Inc.
![]() Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Dugdale Compounds Ltd.
![]() Dugdale Compounds Ltd. Chemicals: SpecialtyProcess Industries Dugdale Compounds Ltd. operates as holding company whose subsidiaries manufactures polyvinyl chloride compounds. The company was founded on September 20, 2003 and is headquartered in Halifax, the United Kingdom. | Chemicals: Specialty | Director/Board Member | |
TANGO THERAPEUTICS, INC. | Biotechnology | Public Communications Contact | |
Evotec (UK) Ltd.
![]() Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 22 |
Vereinigtes Königreich | 13 |
China | 3 |
Dänemark | 3 |
Finnland | 2 |
Sektoral
Health Technology | 15 |
Consumer Services | 13 |
Finance | 10 |
Technology Services | 5 |
Commercial Services | 4 |
Operativ
Director/Board Member | 35 |
Corporate Officer/Principal | 27 |
Chief Tech/Sci/R&D Officer | 14 |
Undergraduate Degree | 10 |
Doctorate Degree | 8 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
C. Nicholson | 22 |
Elizabeth Crain | 17 |
Robert Ghenchev | 13 |
Joanne Xu | 9 |
John Overington | 7 |
Ben Taylor | 7 |
Amanda Galgay | 6 |
Michael Krams | 4 |
Chris Thomas | 4 |
Garry Pairaudeau | 4 |
David Hallett | 4 |
Sara Blum Sherman | 4 |
Richard Henry Cheetham Bickerton | 3 |
Charlotte Deane | 3 |
Adrian Schreyer | 2 |
- Börse
- Insiders
- Xia Milly Chen
- Unternehmensverbindungen